Revenue increased 5% to $138.9 million, with gross margin expanding 50 basis points to 32.7% and operating income improving 6 ...
Decelerating growth and heavy capex make sustained high revenue and FCF margins unrealistic for TransMedics. Read why TMDX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results